Citigroup Inc Ani Pharmaceuticals Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 27,498 shares of ANIP stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,498

Previous 16,442 67.24%

Holding current value

$1.55 Million

Previous $1.05 Million 56.64%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$54.33 - $65.72 $600,672 - $726,600	11,056 Added 67.24%	27,498 $1.64 Million
Q2 2024 Aug 12, 2024	SELL	$58.53 - $68.82 $101,608 - $119,471	-1,736 Reduced 9.55%	16,442 $1.05 Million
Q1 2024 May 10, 2024	BUY	$54.2 - $69.69 $210,350 - $270,466	3,881 Added 27.15%	18,178 $1.26 Million
Q4 2023 Feb 09, 2024	BUY	$48.72 - $65.43 $279,214 - $374,979	5,731 Added 66.9%	14,297 $788,000
Q3 2023 Nov 09, 2023	SELL	$50.28 - $64.61 $106,141 - $136,391	-2,111 Reduced 19.77%	8,566 $497,000
Q2 2023 Aug 10, 2023	BUY	$37.29 - $53.83 $163,404 - $235,883	4,382 Added 69.61%	10,677 $574,000
Q1 2023 May 11, 2023	SELL	$37.61 - $45.72 $63,034 - $76,626	-1,676 Reduced 21.03%	6,295 $250,000
Q4 2022 Feb 09, 2023	BUY	$31.9 - $41.95 $33,048 - $43,460	1,036 Added 14.94%	7,971 $320,000
Q3 2022 Nov 10, 2022	SELL	$29.83 - $38.01 $26,548 - $33,828	-890 Reduced 11.37%	6,935 $223,000
Q2 2022 Aug 10, 2022	SELL	$23.09 - $33.46 $108,315 - $156,960	-4,691 Reduced 37.48%	7,825 $232,000
Q1 2022 May 12, 2022	BUY	$26.91 - $47.15 $104,437 - $182,989	3,881 Added 44.94%	12,516 $352,000
Q4 2021 Feb 10, 2022	BUY	$32.97 - $56.85 $88,128 - $151,960	2,673 Added 44.83%	8,635 $398,000
Q3 2021 Nov 10, 2021	BUY	$26.48 - $35.99 $157,873 - $214,572	5,962 New	5,962 $196,000

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account